SteadyMed Files Inter Partes Review to Invalidate United Therapeutics Patent
October 21, 2015 07:00 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., Oct. 21, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value...
SteadyMed to Participate in Upcoming Investor Conferences
September 02, 2015 07:30 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., Sept. 2, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value...
SteadyMed to Provide Insights on Recent Corporate Developments and Report Second Quarter 2015 Financial Results
August 06, 2015 07:30 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value diseases...
CORRECTING and REPLACING - SteadyMed Reports Recent Developments, Financial Highlights and First Quarter 2015 Financial Results
May 14, 2015 08:53 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., May 14, 2015 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by SteadyMed Ltd. (Nasdaq:STDY), please note that in the first paragraph under the First...
SteadyMed Reports Recent Developments, Financial Highlights and First Quarter 2015 Financial Results
May 14, 2015 07:39 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., May 14, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value diseases...
SteadyMed Granted Additional U.S. Patent With Patent Term Extension
April 22, 2015 07:00 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., April 22, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY) a specialty pharmaceutical company, today announced the issuance of a new patent from the United States Patent and...
SteadyMed Announces Closing of Initial Public Offering
March 25, 2015 14:26 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., March 25, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company, today announced the closing of its initial public offering of 4,700,000 ordinary shares at a...
SteadyMed Announces Pricing of Initial Public Offering
March 20, 2015 07:00 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., March 20, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company, today announced the pricing of its initial public offering of 4,700,000 ordinary shares at a...
SteadyMed Ltd. Launches Initial Public Offering
March 09, 2015 16:01 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., March 9, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company, today announced the launch of its initial public offering of 4,250,000 ordinary shares at an...
SteadyMed Raises $12.2 Million in Equity Financing
January 29, 2015 08:00 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., Jan. 29, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company focused on the development and commercialization of therapeutic product candidates that address...